{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,6,24]],"date-time":"2022-06-24T12:17:05Z","timestamp":1656073025487},"reference-count":50,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2009,10,14]],"date-time":"2009-10-14T00:00:00Z","timestamp":1255478400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Curr Neurol Neurosci Rep"],"published-print":{"date-parts":[[2009,11]]},"DOI":"10.1007\/s11910-009-0063-0","type":"journal-article","created":{"date-parts":[[2009,10,13]],"date-time":"2009-10-13T01:11:28Z","timestamp":1255396288000},"page":"423-429","source":"Crossref","is-referenced-by-count":2,"title":["Management and prevention of human prion diseases"],"prefix":"10.1007","volume":"9","author":[{"given":"Silvia","family":"Graziano","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maurizio","family":"Pocchiari","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2009,10,14]]},"reference":[{"key":"63_CR1","doi-asserted-by":"crossref","first-page":"1586","DOI":"10.1212\/01.WNL.0000160117.56690.B2","volume":"64","author":"A. Ladogana","year":"2005","unstructured":"Ladogana A, Puopolo M, Croes EA, et al.: Mortality from Creutzfeldt-Jakob disease and related disorders in Europe, Australia, and Canada. Neurology 2005, 64:1586\u20131591.","journal-title":"Neurology"},{"key":"63_CR2","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1002\/ana.21294","volume":"63","author":"H.J. Ward","year":"2008","unstructured":"Ward HJ, Everington D, Cousens SN, et al.: Risk factors for sporadic Creutzfeldt-Jakob disease. Ann Neurol 2008, 63:347\u2013354.","journal-title":"Ann Neurol"},{"key":"63_CR3","doi-asserted-by":"crossref","first-page":"2077","DOI":"10.1212\/01.WNL.0000145844.53251.BC","volume":"63","author":"L. Linsell","year":"2004","unstructured":"Linsell L, Cousens SN, Smith PG, et al.: A case-control study of sporadic Creutzfeldt-Jakob disease in the United Kingdom. Analysis of clustering. Neurology 2004, 63:2077\u20132083.","journal-title":"Neurology"},{"key":"63_CR4","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1186\/gm63","volume":"1","author":"M. Pocchiari","year":"2009","unstructured":"Pocchiari M, Poleggi A, Principe S, et al.: Genomic and post-genomic analyses of human prion diseases. Genome Med 2009, 1:63.","journal-title":"Genome Med"},{"key":"63_CR5","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1159\/000163097","volume":"31","author":"I. Mahillo-Fernandez","year":"2008","unstructured":"Mahillo-Fernandez I, de Pedro-Cuesta J, Bleda MJ, et al.: Surgery and risk of sporadic Creutzfeldt-Jakob disease in Denmark and Sweden: registry-based case-control studies. Neuroepidemiology 2008, 31:229\u2013240.","journal-title":"Neuroepidemiology"},{"key":"63_CR6","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1002\/ana.410350504","volume":"35","author":"P. Brown","year":"1994","unstructured":"Brown P, Gibbs CJ Jr, Rodgers-Johnson P, et al.: Human spongiform encephalopathy: the National Institutes of Health series of 300 cases of experimentally transmitted disease. Ann Neurol 1994, 35:513\u2013529.","journal-title":"Ann Neurol"},{"key":"63_CR7","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1212\/01.wnl.0000231528.65069.3f","volume":"67","author":"P. Brown","year":"2006","unstructured":"Brown P, Brandel JP, Preese M, Sato T: Iatrogenic Creutzfeldt-Jakob disease. The waning of an era. Neurology 2006, 67:389\u2013393.","journal-title":"Neurology"},{"key":"63_CR8","doi-asserted-by":"crossref","first-page":"3707","DOI":"10.1098\/rstb.2008.0071","volume":"363","author":"M.P. Alpers","year":"2008","unstructured":"Alpers MP: The epidemiology of kuru: monitoring the epidemic from its peak to its end. Phil Trans R Soc B 2008, 363:3707\u20133713.","journal-title":"Phil Trans R Soc B"},{"key":"63_CR9","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1016\/S0140-6736(04)15487-1","volume":"363","author":"C. Herzog","year":"2004","unstructured":"Herzog C, Sal\u00e8s N, Etchegaray N, et al.: Tissue distribution of bovine spongiform encephalopathy agent in primates after intravenous or oral infection. Lancet 2004, 363:422\u2013428.","journal-title":"Lancet"},{"key":"63_CR10","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1093\/brain\/awn303","volume":"132","author":"G.M. Klug","year":"2009","unstructured":"Klug GM, Wand H, Boyd A, et al.: Enhanced geographically restricted surveillance simulates sporadic Creutzfeldt-Jakob disease cluster. Brain 2009, 132:493\u2013501.","journal-title":"Brain"},{"key":"63_CR11","volume-title":"WHO Infection Control Guidelines for Transmissible Spongiform Encephalopathies","author":"World Health Organization","year":"1999","unstructured":"World Health Organization: WHO Infection Control Guidelines for Transmissible Spongiform Encephalopathies. Geneva: World Health Organization; 1999."},{"key":"63_CR12","unstructured":"European and Allied Countries Collaborative Study Group of CJD (EUROCJD), Extended European Collaborative Study Group of CJD (NEUROCJD): Variant Creutzfeldt-Jakob disease current data (July 2009). Available at http:\/\/www.eurocjd.ed.ac.uk\/vcjdworldeuro.htm . Accessed August 2009."},{"key":"63_CR13","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1016\/S0140-6736(01)05411-3","volume":"358","author":"M.E. Bruce","year":"2001","unstructured":"Bruce ME, McConnell I, Will RG, Ironside JW: Detection of variant Creutzfeldt-Jakob disease infectivity in extraneural tissues. Lancet 2001, 358:208\u2013209.","journal-title":"Lancet"},{"key":"63_CR14","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/S0140-6736(01)05403-4","volume":"358","author":"J.D.F. Wadsworth","year":"2001","unstructured":"Wadsworth JDF, Joiner S, Hill AF et al.: Tissue distribution of protease resistant prion protein in variant Creutzfeldt-Jakob disease using a highly sensitive immunoblotting assay. Lancet 2001, 358:171\u2013180.","journal-title":"Lancet"},{"key":"63_CR15","doi-asserted-by":"crossref","first-page":"4739","DOI":"10.1182\/blood-2008-04-152520","volume":"112","author":"F. Houston","year":"2008","unstructured":"Houston F, McCutcheon S, Goldmann W, et al.: Prion diseases are efficiently transmitted by blood transfusion in sheep. Blood 2008, 112:4739\u20134745.","journal-title":"Blood"},{"key":"63_CR16","doi-asserted-by":"crossref","first-page":"1687","DOI":"10.1046\/j.0041-1132.2003.00586.x","volume":"43","author":"L. Cervenakova","year":"2003","unstructured":"Cervenakova L, Yakovleva O, McKenzie C, et al.: Similar levels of infectivity in the blood of mice infected with human-derived vCJD and GSS strains of transmissible spongiform encephalopathy. Transfusion 2003, 43:1687\u20131694.","journal-title":"Transfusion"},{"key":"63_CR17","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1111\/j.1423-0410.2009.01161.x","volume":"96","author":"J. Coste","year":"2009","unstructured":"Coste J, Prowse C, Eglin R, Fang C: A report on transmissible spongiform encephalopathies and transfusion safety. Vox Sang 2009, 96:284\u2013291.","journal-title":"Vox Sang"},{"key":"63_CR18","unstructured":"Bennett P, Ball J: vCJD risk assessment calculations for a patient with multiple routes of exposure. Department of Health, 9 June 2009. Available at http:\/\/www.dh.gov.uk\/en\/Publicationsandstatistics\/Publications\/Publications-PolicyAndGuidance\/DH_100357 . Accessed August 2009."},{"issue":"Suppl5","key":"63_CR19","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1111\/j.1365-2516.2007.01572.x","volume":"13","author":"P. Brown","year":"2007","unstructured":"Brown P: Creutzfeldt-Jakob disease: reflections on the risk from blood product therapy. Haemophilia 2007, 13(Suppl 5):33\u201340.","journal-title":"Haemophilia"},{"key":"63_CR20","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1046\/j.1537-2995.1998.38998409000.x","volume":"38","author":"B. Evatt","year":"1998","unstructured":"Evatt B, Austin E, Barnhart L, et al.: Surveillance for Creutzfeldt-Jakob disease among persons with hemophilia. Transfusion 1998, 38:817\u2013820.","journal-title":"Transfusion"},{"key":"63_CR21","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1111\/j.1537-2995.2008.02056.x","volume":"49","author":"K. Dorsey","year":"2009","unstructured":"Dorsey K, Zou S, Schonberger LB, et al.: Lack of evidence of transfusion transmission of Creutzfeldt-Jakob disease in a US surveillance study. Transfusion 2009, 49:977\u2013984.","journal-title":"Transfusion"},{"key":"63_CR22","unstructured":"Transfusion Medicine Epidemiology Review (TMER). Available at http:\/\/www.cjd.ed.ac.uk\/TMER\/TMER.htm . Accessed August 2009."},{"key":"63_CR23","doi-asserted-by":"crossref","first-page":"1406","DOI":"10.3201\/eid1409.080259","volume":"14","author":"L. Gregori","year":"2008","unstructured":"Gregori L, Kovacs GG, Alexeeva I, et al.: Excretion of transmissible spongiform encephalopathy infectivity in urine. Emerg Infect Dis 2008, 14:1406\u20131412.","journal-title":"Emerg Infect Dis"},{"key":"63_CR24","doi-asserted-by":"crossref","first-page":"e4848","DOI":"10.1371\/journal.pone.0004848","volume":"4","author":"N.J. Haley","year":"2009","unstructured":"Haley NJ, Seelig DM, Zabel MD, et al.: Detection of CWD prions in urine and saliva of deer by transgenic mouse bioassay. PLoS One 2009, 4:e4848.","journal-title":"PLoS One"},{"key":"63_CR25","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1051\/vetres:2008018","volume":"39","author":"C.J. Sigurdson","year":"2008","unstructured":"Sigurdson CJ: A prion disease of cervids: chronic wasting disease. Vet Res 2008, 39:41.","journal-title":"Vet Res"},{"key":"63_CR26","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1126\/science.1129051","volume":"313","author":"P. Sa\u00e1","year":"2006","unstructured":"Sa\u00e1 P, Castilla J, Soto C: Presymptomatic detection of prions in blood. Science 2006, 313:92\u201394.","journal-title":"Science"},{"key":"63_CR27","doi-asserted-by":"crossref","first-page":"4712","DOI":"10.1073\/pnas.0609241104","volume":"104","author":"P. Piccardo","year":"2007","unstructured":"Piccardo P, Manson JC, King D, et al.: Accumulation of prion protein in the brain that is not associated with transmissible disease. Proc Natl Acad Sci U S A 2007, 104:4712\u20134717.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"63_CR28","doi-asserted-by":"crossref","first-page":"6855","DOI":"10.1093\/emboj\/18.23.6855","volume":"18","author":"J.C. Manson","year":"1999","unstructured":"Manson JC, Jamieson E, Baybutt H, et al.: A single amino acid alteration (101L) introduced into murine PrP dramatically alters incubation time of transmissible spongiform encephalopathy. EMBO J 1999, 18:6855\u20136864.","journal-title":"EMBO J"},{"key":"63_CR29","doi-asserted-by":"crossref","first-page":"b1442","DOI":"10.1136\/bmj.b1442","volume":"338","author":"J.P. Clewley","year":"2009","unstructured":"Clewley JP, Kelly CM, Andrews N, et al.: Prevalence of disease related prion protein in anonymous tonsil specimens in Britain: cross sectional opportunistic survey. BMJ 2009, 338:b1442.","journal-title":"BMJ"},{"key":"63_CR30","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1093\/bmb\/66.1.213","volume":"66","author":"P. Gambetti","year":"2003","unstructured":"Gambetti P, Kong Q, Zou W, et al.: Sporadic and familial CJD: classification and characterisation. Br Med Bull 2003, 66:213\u2013239.","journal-title":"Br Med Bull"},{"key":"63_CR31","doi-asserted-by":"crossref","first-page":"2632","DOI":"10.1093\/brain\/awn202","volume":"131","author":"T.E. Webb","year":"2008","unstructured":"Webb TE, Poulter M, Beck J, et al.: Phenotypic heterogeneity and genetic modification of P102L inherited prion disease in an international series. Brain 2008, 131:2632\u20132646.","journal-title":"Brain"},{"key":"63_CR32","doi-asserted-by":"crossref","first-page":"1491","DOI":"10.1136\/jnnp.2004.056606","volume":"76","author":"J.J. Zarranz","year":"2005","unstructured":"Zarranz JJ, Digon A, Atar\u00e9s B, et al.: Phenotypic variability in familial prion diseases due to the D178N mutation. J Neurol Neurosurg Psychiatry 2005, 76:1491\u20131496.","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"63_CR33","doi-asserted-by":"crossref","first-page":"1592","DOI":"10.1212\/01.WNL.0000160118.26865.11","volume":"64","author":"A. Ladogana","year":"2005","unstructured":"Ladogana A, Puopolo M, Poleggi A, et al.: High incidence of genetic human transmissible spongiform encephalopathies in Italy. Neurology 2005, 64:1592\u20131597.","journal-title":"Neurology"},{"key":"63_CR34","doi-asserted-by":"crossref","first-page":"2241","DOI":"10.1093\/brain\/awl150","volume":"129","author":"C.R. Trevitt","year":"2006","unstructured":"Trevitt CR, Collinge J: A systematic review of prion therapeutics in experimental models. Brain 2006, 129:2241\u20132265.","journal-title":"Brain"},{"key":"63_CR35","doi-asserted-by":"crossref","first-page":"1272","DOI":"10.1212\/01.wnl.0000308955.25760.c2","volume":"70","author":"L.A. Stewart","year":"2008","unstructured":"Stewart LA, Rydzewska LH, Keogh GF, Knight RS: Systematic review of therapeutic interventions in human prion disease. Neurology 2008, 70:1272\u20131281.","journal-title":"Neurology"},{"key":"63_CR36","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1016\/S1474-4422(09)70049-3","volume":"8","author":"J. Collinge","year":"2009","unstructured":"Collinge J, Gorham M, Hudson F, et al.: Safety and efficacy of quinacrine in human prion disease (PRION-1 study): a patient-preference trial. Lancet Neurol 2009, 8:334\u2013344.","journal-title":"Lancet Neurol"},{"key":"63_CR37","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1111\/j.1468-1331.2008.02108.x","volume":"15","author":"I. Bone","year":"2008","unstructured":"Bone I, Belton L, Walker AS, Darbyshire J: Intraventricular pentosan polysulfate in human prion diseases: an observational study in the UK. Eur J Neurol 2008, 15:458\u2013464.","journal-title":"Eur J Neurol"},{"key":"63_CR38","doi-asserted-by":"crossref","first-page":"2348","DOI":"10.1093\/brain\/awh249","volume":"127","author":"M. Pocchiari","year":"2004","unstructured":"Pocchiari M, Puopolo M, Croes EA, et al.: Predictors of survival in sporadic Creutzfeldt-Jakob disease and other human transmissible spongiform encephalopathies. Brain 2004, 127:2348\u20132359.","journal-title":"Brain"},{"key":"63_CR39","doi-asserted-by":"crossref","first-page":"3802","DOI":"10.1002\/pmic.200900085","volume":"9","author":"A. Giorgi","year":"2009","unstructured":"Giorgi A, Di Francesco L, Principe S, et al.: Proteomic pro-filing of PrP27-30-enriched preparations extracted from the brain of hamsters with experimental scrapie. Proteomics 2009, 9:3802\u20133814.","journal-title":"Proteomics"},{"key":"63_CR40","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1159\/000150553","volume":"40","author":"H. Diringer","year":"1997","unstructured":"Diringer H, Beekes M, \u00d6zel M, et al.: Highly infectious purified preparations of disease-specific amyloid of transmissible spongiform encephalopathies are not devoid of nucleic acids of viral size. Intervirology 1997, 40:238\u2013246.","journal-title":"Intervirology"},{"key":"63_CR41","doi-asserted-by":"crossref","unstructured":"Simoneau S, Ruchoux MM, Vignier N, et al.: Small critical RNAs in the scrapie agent. Available at http:\/\/hdl.handle.net\/10101\/npre.2009.3344.1 . Accessed August 2009.","DOI":"10.1038\/npre.2009.3344.1"},{"key":"63_CR42","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1146\/annurev.neuro.31.060407.125620","volume":"31","author":"A. Aguzzi","year":"2008","unstructured":"Aguzzi A, Baumann F, Bremer J: The prion\u2019s elusive reason for being. Annu Rev Neurosci 2008, 31:439\u2013477.","journal-title":"Annu Rev Neurosci"},{"key":"63_CR43","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1016\/j.neuron.2007.01.005","volume":"53","author":"G.R. Mallucci","year":"2007","unstructured":"Mallucci GR, White MD, Farmer M, et al.: Targeting cellular prion protein reverses early cognitive deficits and neurophysiological dysfunction in prion-infected mice. Neuron 2007, 53:325\u2013335.","journal-title":"Neuron"},{"key":"63_CR44","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1038\/nature03989","volume":"437","author":"J.R. Silveira","year":"2005","unstructured":"Silveira JR, Raymond GJ, Hughson AG, et al.: The most infectious prion protein particles. Nature 2005, 437:257\u2013261.","journal-title":"Nature"},{"key":"63_CR45","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1038\/nrm2101","volume":"8","author":"C. Haass","year":"2007","unstructured":"Haass C, Selkoe DJ: Soluble protein oligomers in neurodegeneration: lessons from the Alzheimer\u2019s amyloid beta-peptide. Nat Rev Mol Cell Biol 2007, 8:101\u2013112.","journal-title":"Nat Rev Mol Cell Biol"},{"key":"63_CR46","doi-asserted-by":"crossref","first-page":"1128","DOI":"10.1038\/nature07761","volume":"457","author":"J. Laur\u00e9n","year":"2009","unstructured":"Laur\u00e9n J, Gimbel DA, Nygaard HB, et al.: Cellular prion protein mediates impairment of synaptic plasticity by amyloid-beta oligomers. Nature 2009, 457:1128\u20131134.","journal-title":"Nature"},{"key":"63_CR47","doi-asserted-by":"crossref","first-page":"e3017","DOI":"10.1371\/journal.pone.0003017","volume":"3","author":"E.E. Comoy","year":"2008","unstructured":"Comoy EE, Casalone C, Lescoutra-Etchegaray N, et al.: Atypical BSE (BASE) transmitted from asymptomatic aging cattle to a primate. PLoS One 2008, 3:e3017.","journal-title":"PLoS One"},{"key":"63_CR48","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1002\/ana.21420","volume":"63","author":"P. Gambetti","year":"2008","unstructured":"Gambetti P, Dong Z, Yuan J, et al.: A novel human disease with abnormal prion protein sensitive to protease. Ann Neurol 2008, 63:697\u2013708.","journal-title":"Ann Neurol"},{"key":"63_CR49","unstructured":"Watts S: Fears raised over new vCJD wave. Available at http:\/\/news.bbc.co.uk\/1\/hi\/health\/7788627.stm . Accessed August 2009."},{"key":"63_CR50","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1016\/S1474-4422(06)70413-6","volume":"5","author":"M.T. Bishop","year":"2006","unstructured":"Bishop MT, Hart P, Aitchison L, et al.: Predicting susceptibility and incubation time of human-to-human transmission of vCJD. Lancet Neurol 2006, 5:393\u2013398.","journal-title":"Lancet Neurol"}],"container-title":["Current Neurology and Neuroscience Reports"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11910-009-0063-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11910-009-0063-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11910-009-0063-0","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,23]],"date-time":"2020-05-23T00:19:56Z","timestamp":1590193196000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11910-009-0063-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,10,14]]},"references-count":50,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2009,11]]}},"alternative-id":["63"],"URL":"https:\/\/doi.org\/10.1007\/s11910-009-0063-0","relation":{},"ISSN":["1528-4042","1534-6293"],"issn-type":[{"value":"1528-4042","type":"print"},{"value":"1534-6293","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,10,14]]}}}